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Introduction
Hypertrophic osteopathy (HO), also called Marie’s dis-
ease, is a polyostotic disease characterised by palisading 
or brush border periosteal proliferation on the diaphysis 
of long bones. In dogs, HO is usually secondary to neo-
plastic (primary or metastatic lung neoplasia) or infec-
tious masses in the thoracic cavity, or, less commonly, in 
the abdominal cavity.1–3 In cats, neoplastic or inflamma-
tory thoracic or abdominal diseases are also the most 
common causes of HO.4–12 However, a cat with megaoe-
sophagus and HO has also been described in the litera-
ture.13 Two reports have described the presence of HO in 
cats with no underlying disease and were therefore 
termed idiopathic.14,15 Primary hypertrophic osteoar-
thropathy or pachydermoperiostosis has been described 
in humans, usually manifesting in young males and 
accounting for approximately 3–5% of cases with hyper-
trophic arthropathy.16–18
Currently, there have been no reported feline cases of 
HO caused by a lesion with no thoracic or abdominal 
involvement. In this report we describe a case of a cat 
with HO and a concurrent soft tissue sarcoma (STS), 
most likely an injection-site sarcoma.
Case description
An 11-year old neutered female domestic shorthair cat 
was admitted to the Queen’s Veterinary School Hospital 
at the University of Cambridge for investigation of a rap-
idly growing mass over the left scapular region. The cat 
had received its annual vaccination (Purevax RCP FeLV; 
Merial) 6 weeks previously and had been missing for 4 
weeks before presentation. On initial presentation to the 
referring veterinarian, a 4 × 5 cm mass was present over 
the left scapular region and the cat was pyrexic (39.5°C). 
Oral treatment with meloxicam 0.1 mg q24h (Metacam; 
Boehringer Ingelheim) and antibiotics 50 mg q12h 
(clavulanic acid and amoxicillin; Pfizer Animal Health) 
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was given for 4 days with no response. On presentation 
at referral 4 days after the cat was presented to the refer-
ring veterinarian, the cat was quiet but alert. Mild 
tachypnoea with an increased inspiratory effort and 
pyrexia (39.5ºC) were noted. The mass over the left scap-
ular region had increased in size since initial presenta-
tion (7 × 5 × 4 cm) and was superficially ulcerated.
Haematology revealed mild anaemia (haematocrit 
19%, reference interval [RI] 26–45%) and marked leuko-
cytosis (140.0 × 109/l, RI 5.5–19.5), with absolute neutro-
philia (133.0 × 109/l, RI 2.5–12.5) and monocytosis 
(4.2 × 109/l, RI 0–1.5). Serum biochemistry was unre-
markable. FeLV/FIV IDEXX SNAP test was negative.
Fine-needle aspiration of the mass revealed neutro-
philic inflammation and mesenchymal cell proliferation. 
Tru-cut needle biopsies were taken under general anaes-
thesia and were consistent with a high-grade STS. Fungal 
and mycobacterial cultures were negative.
Abdominal ultrasound was unremarkable. Thoracic 
radiographs revealed no intrathoracic pathology. A 7 × 
5 cm soft tissue opacity at the level of the left scapula was 
noticed (Figure 1). Incidentally, a mixture of brush bor-
der, palisading and smooth periosteal reaction was seen 
along the diaphysis of the humerus, radius and ulna in 
both forelimbs, and as well on the distal tibia, calcaneus, 
and tarsal and metatarsal bones (Figure 2). These bone 
abnormalities were radiographically consistent with HO.
A magnetic resonance imaging (MRI) examination of 
the mass was performed to assess the extension and aid 
possible surgical planning. The mass was associated 
with the left proximal humerus, being lateral to the left 
scapula and in very close relation to the transverse 
spinous process of the caudal cervical vertebrae. The 
mass (5.5 × 4.5 × 3 cm) was mostly hyperintense to mus-
cle on T1-weighted (T1W) and T2-weighted (T2W) 
images, with internal T1W hypointensities and T2W 
hyperintensities consistent with necrosis (Figure 3). The 
Figure 1 Right lateral view of the thorax, showing no 
pulmonary abnormalities. A mass over one of the shoulders 
is seen (black star), and there is a brush border periosteal 
reaction on the humerus, seen better on the caudal aspect 
(white circle). The periosteal reaction is magnified and marked 
with a white arrowhead. Cranial is to the left of the image
Figure 2 Mediolateral radiographs of the (a,b) left forelimb, (c) right hindlimb and (d) right forelimb, showing a moderate 
amount of a mixed periosteal reaction (palisading, smooth and brush border) on the cranial and caudal cortex of the humerus, 
distal tibia and dorsal aspect of the metatarsi (white arrows), and radius and ulna (white arrowheads). (b) Magnified view of the 
periosteal reaction in the left distal humerus
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mass had ill-defined and irregular margins, and there 
was strong suspicion of muscle invasion. The owners 
elected euthanasia on humane grounds, as they did not 
wish to pursue radical resection of the mass. Post-
mortem examination showed marked rough increased 
periosteal new bone in the diaphysis of long limb bones 
and scapulae (Figure 4a), which had a double cortex-like 
appearance on transverse sections. Microscopically, the 
mass revealed invasion of the skin, dermis, subcutane-
ous tissue and skeletal muscle with spindloid-shaped 
neoplastic cells was noted. Fibrin deposition and necro-
sis, and a mitotic rate of 0–3/high power field were 
noted (Figure 4b). There was marked periosteal reaction 
with new woven bone tissue in the diaphysis of the long 
bones. The new bone formed was cancellous to compact 
with large number of osteoblasts and osteocytes. There 
was clear distinction from the new bone with the normal 
compact bone (Figure 4c). These changes were character-
istic for HO. Other post-mortem findings include mild 
pulmonary congestion and oedema, mild hepatitis and 
splenic lymphoid depletion. A cystic thyroid adenoma 
on the right thyroid lobe was found.
The gross post-mortem findings, microscopic exami-
nation, and clinical and radiological findings confirmed 
the presence of a high-grade STS, most likely an injection-
site sarcoma, in the left scapular region, and HO.
Discussion
The exact pathogenesis of HO is still unknown and sev-
eral theories have been suggested, including irritation 
of the periosteum by circulating toxins from the primary 
lesions, changes in the peripheral blood flow to the 
distal extremities, neurogenic mechanisms, afferent 
impulses that travel in the vagus and intercostal nerves 
from the lesion to the central nervous system and 
develop the HO, and distal vascular release of platelet-
derived growth factor and vascular endothelial growth 
factor.1–3 The mechanism for the development of HO in 
this case was not determined; however, it is possible 
that any or all of the proposed mechanisms could have 
contributed.
HO is commonly seen in middle-aged male cats, 
Persian and Persian crosses.3 The most common present-
ing sign is moderate-to-severe lameness with the under-
lying cause typically identified as an incidental 
finding.1–15 Interestingly, this cat did not have any clini-
cal signs of lameness and no pain or swelling of the long 
bones was found in the general examination. It is possi-
ble the STS progression was more rapid than the devel-
opment of clinical signs associated with HO in this case, 
as the periosteal reaction was only moderate.
Only one other case of HO associated with a sarcoma 
in a cat has been described in the literature; however, this 
was a pulmonary sarcoma in keeping with the intratho-
racic pathology history seen with HO in cats.6 
Furthermore, no other reports of STS with HO have been 
previously described in cats or humans. Owing to the 
vaccination history, localisation of the mass, MRI charac-
teristics and histopathology, the most likely final diagno-
sis was an injection-site sarcoma.
Feline injection-site STSs are thought to be caused by 
an anomalous response to a chronic local inflammation 
after vaccine administration, long-acting antibiotics, 
methylprednisolone or non-absorbable suture material. 
They have a very rapid growth, are locally invasive and 
have a low distant metastatic rate.19–22 Generally, STS 
occurs at 6–7 years or 10–11 years, as in our case.22
MRI characteristics of injection-site STSs have been 
recently described showing a wide variability, but all 
tumours were hyperintense relative to surrounding 
muscles on T1W and T2W images, similar to this 
case.23
Although it is impossible to define causation of the 
HO with STS, given the lack of other causative features 
(thoracic or abdominal abnormalities), the presence of 
the STS causing HO is highly likely. The thyroid adenoma 
Figure 3 (a) Mediolateral oblique radiograph of the left elbow, with a large soft tissue mass over the scapula–humeral joint 
(black star). (b) T1-weighted transverse image at the level of the proximal humeral metaphysis, showing a mostly hyperintense 
mass lateral to the left shoulder joint (black star), with a focal area of necrosis. (c) T2-weighted image, showing the same 
changes as in (b) but in this case the area of necrosis is hyperintense. Left is to the right of the image
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is unlikely to be the cause of HO in this case, as no other 
reports of HO associated with thyroid adenoma have 
been published in the literature. Only one human report 
with thyroid cancer and secondary HO has been 
reported; however, in that case, HO only developed once 
pulmonary metastases were present.24
In human medicine HO has been associated with 
cyanotic congenital heart disease.25 Mild pulmonary 
congestion was identified in the post-mortem examina-
tion of this case, most likely related to the euthanasia as 
no cardiovascular abnormalities were found in this cat 
on post-mortem examination.
An idiopathic HO in this case is also unlikely. Only 
eight cats with suspected idiopathic HO have previously 
been reported.14,15 Although we cannot completely 
exclude the possibility of an idiopathic HO and a STS 
occurring independently from each other in this case, it 
is far more likely that the origin of HO in this case is 
related to the STS as, by definition, HO usually develops 
secondary to another disease process, for example neo-
plasia or inflammation, and additionally all human and 
veterinary cases of primary HO have clinical signs due 
to the periosteal reaction, which this cat lacked.16–18
Resolution of the HO after surgical removal of the pri-
mary lesion has been reported.9 In the present case, con-
firmation of the association of HO and STS would have 
included the resolution of the periosteal reaction after 
surgical resection of the mass, which was not performed 
at the owners’ request.
Conclusions
This report describes the first case of a cat with an STS 
(likely an injection-site STS) with secondary HO. HO can 
also occur in cats where no lameness or swollen limbs 
and pain are present. We recommend radiographing the 
distal limbs and including HO as a differential in cases 
when STS and lameness are present. Further research 
is needed to identify the exact connection between 
injection-site STS and HO in cats.
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